Microdosing is not FDA-approved or clinically studied for either peptide
That is why protein intake and resistance training are the two non-negotiables of any GLP-1 routine, and why the smartest supplement choices are the ones that defend muscle and fill the specific holes lower intake leaves behind
This complexity underscores the need for stage-specific interventions: acute mitochondrial injury may respond to antioxidants or metabolic substrates, while advanced disease may require reprogramming of cellular bioenergetics
Who Can Experience Retatrutide Benefits Not everyone is an ideal candidate for Retatrutide
In Phase 3 TRIUMPH-1 data, nausea was reported in 28.6% of participants taking 4 mg, 38.4% taking 9 mg, and 42.4% taking 12 mg, compared with 14.8% of participants receiving placebo
our honest answer is: it depends entirely on your labs and your goals